시장보고서
상품코드
1299754

체외 독성 시험 시장 : 기술별, 용도별, 방법별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

In-vitro Toxicology Testing Market with COVID-19 Impact Analysis, By Technology, By Application, By Method, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 387 Pages | 배송안내 : 2-3일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서의 하이라이트

체외 독성 시험 시장 규모는 2022년 294억 230만 달러로 2023년부터 2030년까지 12.3%의 CAGR로 확대

체외 독성 시험 시장 - 시장 역학:

동물 실험 금지에 초점을 맞춘 정부 이니셔티브가 증가함에 따라 체외 독성 시험의 채택이 확대될 것으로 예상할 수 있습니다. 또한, 다양한 민간 및 정부 기관이 체외 독성 시험 접근법 개발을 위해 연구 커뮤니티에 자금 지원 기회와 프로그램을 제공하는 데 관여하고 있습니다. 이는 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다. 그러나 낮은 인지도와 숙련된 전문가 부족은 시장 성장을 저해하는 주요 요인입니다.

또한, 의료 기술의 발전과 독성 데이터베이스의 증가는 체외 독성 시험 시장 성장에 큰 기회를 제공할 것입니다. 또한, 체외 독성 시험 방법을 이용한 개인 맞춤형 의료 및 신약 개발에 대한 관심이 높아짐에 따라 체외 독성 시험 시장의 성장이 확대될 것으로 예상되며, COVID-19의 대유행으로 인해 세계 체외 독성 시험 시장에서 많은 기업들이 사업을 중단해야 했습니다. 가동 중단 기간 동안 인력과 원자재 부족으로 인해 산업 제품 생산이 지연되고 있습니다.

체외 독성 시험 시장 - 세분화 분석:

세계 체외 독성 시험 시장은 기술, 용도, 방법, 최종사용자 및 지역에 따라 세분화됩니다.

기술은 세포배양 기술, 하이스루풋 기술, 분자 이미징 기술, 오믹스(OMICS) 기술입니다. 세포 배양 기술 부문이 우위를 유지할 것으로 보입니다. 일관된 샘플을 얻기 위해 세포배양은 재현성 있는 결과를 제공하며 독성 분석에서 우수한 모델 역할을 합니다. 또한, 제약회사, 의료 학술 기관 및 생명공학 산업은 동물 실험과 비교하여 세포 배양 기술을 채택하고 있습니다.

이 시장은 용도에 따라 전신독성학, 경피독성학, 내분비계 장애, 안독성학, 기타로 분류됩니다. 전신 독성 분야는 예측 기간 동안 성장할 것으로 예상됩니다. 전신 독성 시험에는 만성 전신 독성, 아만성 전신 독성, 급성 전신 독성, 아급성 전신 독성 등이 있습니다. 이를 통해 최대 내약성을 나타내는 최소 용량, 독성, 독성과 직결되는 혈장 농도, 의사결정에 도움이 되는 안전성 마진 등 정확한 데이터 포인트를 생성하는 것을 목표로 합니다.

이 시장은 방법론에 따라 세포 분석, 생화학 분석, in-silico, ex-vivo로 나뉩니다. 세포 분석 분야가 시장 수익을 주도할 가능성이 높습니다. 세포 분석은 가장 우수한 모델이며 약물의 약동학 프로파일을 식별하는 데 널리 사용할 수 있습니다.

시장은 최종사용자에 따라 제약 산업, 화장품 및 생활용품, 학술 기관 및 연구소, 진단, 화학 산업, 식품 산업으로 나뉩니다. 제약 산업이 시장 성장을 주도할 가능성이 높습니다. 의약품의 약동학적 특성을 분석하기 위해 독성 검사가 많이 사용되기 때문에 이 분야의 수요를 촉진할 것으로 보입니다.

체외 독성 시험 시장 - 경쟁 상황:

체외 독성 시험 시장의 성장을 견인한 요인은 3D 세포배양의 발전입니다. 또한, 연구 개발 절차의 증가는 체외 독성 시험 시장의 성장을 더욱 가속화할 수 있는 기회로 작용할 것으로 보입니다. 또한, 시장 참여자들은 파트너십, 제품 혁신, 협업, M&A와 같은 사업 확장을 위한 전략을 채택하고 있습니다. 예를 들어, 2021년 1월 Charles River는 표적치료제 스크리닝 및 암 면역치료 분야에서 Cypre, Inc.와의 제휴를 발표했습니다. 이 제휴를 통해 Charles River의 고객들은 Cypre의 독자적인 3D 종양 모델 플랫폼인 Falcon-X(TM)에 접근할 수 있으며, Charles River의 3D를 확장하여 환자에 대한 면역종양학적인 접근 방식을 더욱 분석할 수 있게 됩니다.

연구의 주요 특징

이 체외 독성 시험 시장에 대한 조사 보고서는 2022년을 기준 연도로 하여 시장 규모, CAGR, 추정 및 예측(2023-2030년)을 제공합니다.

조사 보고서는 다양한 부문/국가에 걸쳐 잠재적인 성장 기회를 파악하고 체외 독성 시험 시장의 매력적인 투자 제안 매트릭스를 설명합니다.

이 보고서는 전반적인 보고서에서 새로운 투자 기회, 기존 기업이 직면한 과제, 체외 독성 시험 시장에서 지속가능한 성장 요인을 확인했습니다.

COVID-19가 체외 독성 시험 시장 규모, 예측, CAGR, 시장 역학에 미치는 영향에 대해 연구 범위에서 자세히 논의하고, 코로나 이후 체외 독성 시험 시장에 대한 심층적인 인사이트도 다루고 있습니다.

이 보고서의 사용자에게 체외 독성 시험 시장에 대한 종합적인 관점을 제공하기 위해 체외 독성 시험 시장의 경쟁 상황과 주요 혁신가 분석도 포함되어 있습니다.

이 연구는 시장 규모, 성장률, 매력도를 기준으로 모든 산업 부문을 벤치마킹한 성장 전망 매핑 분석을 포함하고 있습니다.

주요 시장 진입 기업의 상세한 기업 개요를 수록하여 체외 독성 시험 시장에서 활동하는 기업의 재무 정보 및 전략적 이니셔티브를 이해하는 데 도움이 될 수 있도록 했습니다.

또한, 이 보고서는 세계뿐만 아니라 지역적 차원에서도 주요 인수합병, 제휴 및 합작투자, 신제품 출시, 연구개발, 지역적 진출 등 주요 시장 참여자들의 중요한 인수합병, 제휴 및 합작투자, 신제품 출시, 지역적 진출도 함께 살펴볼 수 있습니다.

이 조사 보고서는 주로 공급 업체, 투자자, 신규 진입자, 유통 업체, 금융 분석가 등 이 업계의 다양한 이해 관계자를 대상으로 합니다.

목차

제1장 체외 독성 시험 시장 개요

  • 조사 범위

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 체외 독성 시험 주요 시장 동향

  • 체외 독성 시험 시장 성장 촉진요인
  • 체외 독성 시험 시장 성장 억제요인
  • 체외 독성 시험 시장 기회
  • 체외 독성 시험 시장 전망 동향

제4장 체외 독성 시험 업계 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 체계 분석

제5장 체외 독성 시험 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 체외 독성 시험 시장 상황

  • 체외 독성 시험 시장 점유율 분석, 2022년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 체외 독성 시험 시장 - 기술별

  • 개요
    • 기술별 부문 점유율 분석
    • 세포배양 기술
    • 하이스루풋 기술
    • 분자 이미징
    • 오믹스 기술

제8장 체외 독성 시험 시장 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 폴리머

제9장 체외 독성 시험 시장 - 방법별

  • 개요
    • 부문 점유율 분석(방법별)
    • 전신 독성학
    • 경피 독성
    • 내분비 교란
    • 눈 독성
    • 기타

제10장 체외 독성 시험 시장 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 제약 산업
    • 화장품 및 가정용품
    • 학술기관 및 조사기관
    • 진단
    • 화학 산업
    • 식품 업계

제11장 체외 독성 시험 시장 - 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 체외 독성 시험 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 체외 독성 시험 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 체외 독성 시험 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 체외 독성 시험 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 체외 독성 시험 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 - 체외 독성 시험 업계

  • 경쟁 대시보드
  • 기업 개요
    • Helsinn Holding SA
    • Evotec SE
    • Laboratory Corporation of America Holdings
    • Thermo Fisher Scientific, Inc.
    • Quest Diagnostics Incorporated
    • Heron Therapeutics Inc
    • Charles River Laboratories International, Inc.
    • TESARO INC.
    • Bio-Rad Laboratories, Inc.
    • BioIVT
    • ACACIA PHARMA GROUP PLC
    • General Electric Company
    • Eurofins Scientific

제13장 애널리스트의 전방위적 전망

ksm 23.08.16

REPORT HIGHLIGHT

In-vitro toxicology testing market size was valued at USD 29,402.3 Million in 2022, expanding at a CAGR of 12.3% from 2023 to 2030.

In vitro toxicity testing (IVTT) is mainly used for medication development to assess the safety and according to their potency for ranking the chemicals. Additionally in vitro is a term that helps examine hazardous chemicals on a section of an organism that has been isolated. Moreover, it is utilized to identify toxicity at the early stages of the development of new products including food additives, drugs, and cosmetics. Further, in vitro, toxicity testing can also be used to determine distribution, excretion (ADME), drug absorption, threshold response, and metabolism.

In-vitro Toxicology Testing Market- Market Dynamics:

Rising government initiatives focused on banning animal testing can be anticipated to the increasing adoption of in-vitro toxicology testing. In addition, various private agencies and government bodies are involved in providing funding opportunities and programs to research communities for the development of in-vitro test approaches. This in turn projected to drive the market growth over the forecast period. However, less awareness and a lack of skilled professionals are major factors that may hinder the market growth.

Moreover, advancements in medical technology and the increasing number of toxicology databases will offer massive opportunities for the in-vitro toxicology testing market growth. Further, personalized medicine using in vitro methods and a rising focus on drug discovery is anticipated to expand the in-vitro toxicology testing market's growth. The COVID-19 pandemic forced many companies to halt business operations in the global in vitro toxicity testing market. There is a delay in the manufacturing of industrial products due to a lack of manpower and raw materials during the lockdown period.

In-vitro Toxicology Testing Market- Segmentation Analysis:

The global in-vitro toxicology testing market is segmented on the basis of technology, application, method, end-user, and region.

The market is divided into three categories based on technology: cell culture technology, high throughput technology, molecular imaging, and OMICS technology. The cell culture technology segment is likely to maintain its dominance. To consistent samples, cell cultures offer reproducible results, for toxicology assays they serve as an excellent model. Additionally, pharmaceutical manufacturers, healthcare academic institutions, and biotechnology industries have adopted cell culturing technology in comparison to animal testing.

The market is divided into two categories based on application: systemic toxicology, dermal toxicity, endocrine disruption, ocular toxicity, and others. The systemic toxicology sector is anticipated to grow over the forecast period. Several types of systemic toxicology studies include chronic systemic toxicity, sub-chronic systemic toxicity, acute systemic toxicity, and sub-acute systemic toxicity. As a result, the aim is to generate precise data points such as minimum dose that results in maximum tolerated dose, toxicity, and plasma concentration which direct to toxicity and margin of safety that helps to make decisions.

The market is divided into two categories based on method: cellular assay, biochemical assay, in-silico, and ex-vivo. The cellular assay sector is likely to hold the market revenue. The cellular assay is the best model and is available broadly for identifying the pharmacokinetic profile of drugs and it further attributes to the high revenue in the in-vitro toxicology testing market.

The market is divided into two categories based on end-user: pharmaceutical industry, cosmetics & household products, academic institutes & research laboratories, diagnostics, chemicals industry, and food industry. The pharmaceutical industry sector is likely to possess market growth. For analyzing the pharmacokinetic properties of pharmaceutical drugs the high use of toxicology testing is attributed to propel segment demand.

In-vitro Toxicology Testing Market-Competitive Landscape:

The factor that resulted in the expansion of in vitro toxicity testing market is the development of 3D cell culture. Additionally, rising research & development procedures will likely act as an opportunity that further accelerate the in-vitro toxicology testing market's growth. Moreover, market players are adopting strategies to enlarge their business including partnerships, product innovation, collaboration, and mergers & acquisitions. For instance, in January 2021, Charles River a company announced a partnership with Cypre, Inc. for Targeted Therapy Drug Screening and Cancer Immunotherapy. Additionally, the partnership will offer Charles River clients access to Cypre's proprietary 3D tumor model platform, Falcon-X™, which will expand Charles River's 3D to further analyze immuno-oncological approaches for its patients.

Key features of the study:

This proposed research study on in-vitro toxicology testing market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for in-vitro toxicology testing market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the in-vitro toxicology testing market.

Impact of COVID-19 on in-vitro toxicology testing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on in-vitro toxicology testing market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the in-vitro toxicology testing market, we have also included competitive landscape and key innovator analysis for the in-vitro toxicology testing market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the in-vitro toxicology testing market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global in-vitro toxicology testing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET KEY PLAYERS

  • Helsinn Holding S.A.
  • Evotec S.E.
  • Laboratory Corporation of America Holdings
  • Thermo Fisher Scientific, Inc.
  • Quest Diagnostics Incorporated
  • Heron Therapeutics Inc
  • Charles River Laboratories International, Inc.
  • TESARO INC.
  • Bio-Rad Laboratories, Inc.
  • BioIVT
  • ACACIA PHARMA GROUP PLC
  • General Electric Company
  • Eurofins Scientific

GLOBALIN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY

  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • OMICS Technology

GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY APPLICATION

  • Systemic Toxicology
  • Dermal Toxicity
  • Endocrine Disruption
  • Occular Toxicity
  • Others

GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD

  • Cellular Assay
  • Biochemical Assay
  • In-silico
  • Ex-vivo

GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY END-USER

  • Pharmaceutical Industry
  • Cosmetics & Household Products
  • Academic Institutes & Research Laboratories
  • Diagnostics
  • Chemicals Industry
  • Food Industry

GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. In-vitro Toxicology Testing Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. In-vitro Toxicology Testing Market Snippet by Technology
    • 2.1.2. In-vitro Toxicology Testing Market Snippet by Application
    • 2.1.3. In-vitro Toxicology Testing Market Snippet by Method
    • 2.1.4. In-vitro Toxicology Testing Market Snippet by End-User
    • 2.1.5. In-vitro Toxicology Testing Market Snippet by Country
    • 2.1.6. In-vitro Toxicology Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. In-vitro Toxicology Testing Key Market Trends

  • 3.1. In-vitro Toxicology Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. In-vitro Toxicology Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. In-vitro Toxicology Testing Market Opportunities
  • 3.4. In-vitro Toxicology Testing Market Future Trends

4. In-vitro Toxicology Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. In-vitro Toxicology Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. In-vitro Toxicology Testing Market Landscape

  • 6.1. In-vitro Toxicology Testing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. In-vitro Toxicology Testing Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2022&2030 (%)
    • 7.1.2. Cell Culture Technology
    • 7.1.3. High Throughput Technology
    • 7.1.4. Molecular Imaging
    • 7.1.5. OMICS Technology

8. In-vitro Toxicology Testing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 8.1.2. Steel
    • 8.1.3. Polymer

9. In-vitro Toxicology Testing Market - By Method

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Method, 2022&2030 (%)
    • 9.1.2. Systemic Toxicology
    • 9.1.3. Dermal Toxicity
    • 9.1.4. Endocrine Disruption
    • 9.1.5. Occular Toxicity
    • 9.1.6. Others

10. In-vitro Toxicology Testing Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2022&2030 (%)
    • 10.1.2. Pharmaceutical Industry
    • 10.1.3. Cosmetics & Household Products
    • 10.1.4. Academic Institutes & Research Laboratories
    • 10.1.5. Diagnostics
    • 10.1.6. Chemicals Industry
    • 10.1.7. Food Industry

11. In-vitro Toxicology Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. In-vitro Toxicology Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. In-vitro Toxicology Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. In-vitro Toxicology Testing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. In-vitro Toxicology Testing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. In-vitro Toxicology Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- In-vitro Toxicology Testing Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Helsinn Holding S.A.
    • 12.2.2. Evotec S.E.
    • 12.2.3. Laboratory Corporation of America Holdings
    • 12.2.4. Thermo Fisher Scientific, Inc.
    • 12.2.5. Quest Diagnostics Incorporated
    • 12.2.6. Heron Therapeutics Inc
    • 12.2.7. Charles River Laboratories International, Inc.
    • 12.2.8. TESARO INC.
    • 12.2.9. Bio-Rad Laboratories, Inc.
    • 12.2.10. BioIVT
    • 12.2.11. ACACIA PHARMA GROUP PLC
    • 12.2.12. General Electric Company
    • 12.2.13. Eurofins Scientific

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제